| 1 | webinar on codesign in | | | | | | | 2 | 0.44% |
| 2 | provide services for the | | | | | | | 2 | 0.44% |
| 3 | contact us join eptri | | | | | | | 1 | 0.22% |
| 4 | entitled “innovative research read | | | | | | | 1 | 0.22% |
| 5 | atmps as therapy options | | | | | | | 1 | 0.22% |
| 6 | – atmps as therapy | | | | | | | 1 | 0.22% |
| 7 | interview with the expert | | | | | | | 1 | 0.22% |
| 8 | more interview with the | | | | | | | 1 | 0.22% |
| 9 | read more interview with | | | | | | | 1 | 0.22% |
| 10 | research read more interview | | | | | | | 1 | 0.22% |
| 11 | “innovative research read more | | | | | | | 1 | 0.22% |
| 12 | coauthored the research paper | | | | | | | 1 | 0.22% |
| 13 | therapy options in europe | | | | | | | 1 | 0.22% |
| 14 | have coauthored the research | | | | | | | 1 | 0.22% |
| 15 | directors have coauthored the | | | | | | | 1 | 0.22% |
| 16 | of directors have coauthored | | | | | | | 1 | 0.22% |
| 17 | board of directors have | | | | | | | 1 | 0.22% |
| 18 | our board of directors | | | | | | | 1 | 0.22% |
| 19 | of our board of | | | | | | | 1 | 0.22% |
| 20 | members of our board | | | | | | | 1 | 0.22% |
| 21 | and adriana ceci both | | | | | | | 1 | 0.22% |
| 22 | bonifazi and adriana ceci | | | | | | | 1 | 0.22% |
| 23 | as therapy options in | | | | | | | 1 | 0.22% |
| 24 | in europe apr 28 | | | | | | | 1 | 0.22% |
| 25 | options in europe apr | | | | | | | 1 | 0.22% |
| 26 | and the formulation of | | | | | | | 1 | 0.22% |
| 27 | a need to provide | | | | | | | 1 | 0.22% |
| 28 | is a need to | | | | | | | 1 | 0.22% |
| 29 | there is a need | | | | | | | 1 | 0.22% |
| 30 | diseases there is a | | | | | | | 1 | 0.22% |
| 31 | rare diseases there is | | | | | | | 1 | 0.22% |
| 32 | for rare diseases there | | | | | | | 1 | 0.22% |
| 33 | strategy for rare diseases | | | | | | | 1 | 0.22% |
| 34 | national strategy for rare | | | | | | | 1 | 0.22% |
| 35 | the formulation of a | | | | | | | 1 | 0.22% |
| 36 | europe and the formulation | | | | | | | 1 | 0.22% |
| 37 | donato bonifazi and | | | | | | | 1 | 0.22% |
| 38 | in europe and the | | | | | | | 1 | 0.22% |
| 39 | developments in europe and | | | | | | | 1 | 0.22% |
| 40 | political developments in europe | | | | | | | 1 | 0.22% |